United States · FDA National Drug Code directory
Everolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49884-160_bf8637b9-79c5-42fc-8de0-b6209ad745f0
- Product NDC
- 49884-160
- Form
- TABLET
- Composition / generic term
- Everolimus
- Labeler
- Par Health USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221216
- Source listing expiry
- 20261231
Source-listed ingredients
- EVEROLIMUS — .75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BLISTER PACK in 1 CARTON (49884-160-02) / 10 TABLET in 1 BLISTER PACK (49884-160-52) · 49884-160-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →